title: Adrenocorticotropin normalizes the blood levels of nitric oxide in hemorrhage-shocked rats.
abstract: Anesthetized rats were subjected to volume-controlled hemorrhagic shock by stepwise bleeding. Besides cardiovascular and respiratory functions, nitric oxide (NO)-hemoglobin formation in arterial blood was directly evaluated by means of electron spin resonance spectroscopy. During hemorrhagic shock there was a massive increase in NO-hemoglobin, associated with a fall in mean arterial pressure, pulse pressure, respiratory rate and heart rate, and there was a further increase in NO-hemoglobin 15 min after intravenous (i.v.) treatment with saline. All rats died within 30 min. The reversal of the shock condition induced by the i.v. injection of the adrenocorticotropin (ACTH) fragment 1-24 (160 microg/kg, 5 min after bleeding termination) was associated with a prompt disappearance of NO-hemoglobin. Also S-methylisothiourea (3 mg/kg i.v.), a selective inhibitor of inducible NO synthase, provoked a disappearance of NO-hemoglobin and reversal of the shock condition. The present results provide a direct demonstration that volume-controlled hemorrhagic shock is associated with highly increased blood levels of NO, as indicated by increased NO-hemoglobin, and indicate that ACTH-induced reversal of the shock condition is associated with the normalization of NO blood levels, and a parallel improvement of cardiovascular and respiratory functions. This occurs probably through the inhibition of inducible NO synthase, as suggested by the fact that S-methylisothiourea, a selective inhibitor of this NO synthase isoform, produced the same results.
authors.affiliation: Department of Biomedical Sciences, University of Modena, Italy. farmacol@unimo.it
authors.forename: S
authors.initials: S
authors.lastname: Guarini
authors.forename: A
authors.initials: A
authors.lastname: Bini
authors.forename: C
authors.initials: C
authors.lastname: Bazzani
authors.forename: G M
authors.initials: GM
authors.lastname: Ricigliano
authors.forename: M M
authors.initials: MM
authors.lastname: Cainazzo
authors.forename: A
authors.initials: A
authors.lastname: Tomasi
authors.forename: A
authors.initials: A
authors.lastname: Bertolini
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis*; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009569:Nitric Oxide / Q000032:analysis* / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D012119:Respiration / Q000187:drug effects; D012771:Shock, Hemorrhagic / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000324:Adrenocorticotropic Hormone; D006442:Glycated Hemoglobin; D009569:Nitric Oxide; C058377:hemoglobin A, glycosylated-nitric oxide complex